当前位置:
X-MOL 学术
›
Russ. Chem. Bull.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Three-component green synthesis of 6-ethoxycarbonyl-5-methyl-7-(thien-2-yl)-4,7-dihydro[1,2,4]triazolo[1,5-a]pyrimidine, a promising antituberculosis drug
Russian Chemical Bulletin ( IF 1.7 ) Pub Date : 2019-12-01 , DOI: 10.1007/s11172-019-2698-6 Yu. A. Titova , O. V. Fedorova , G. L. Rusinov , V. N. Charushin
Russian Chemical Bulletin ( IF 1.7 ) Pub Date : 2019-12-01 , DOI: 10.1007/s11172-019-2698-6 Yu. A. Titova , O. V. Fedorova , G. L. Rusinov , V. N. Charushin
A new simple, technological, and environmentally friendly method for the catalyst-free synthesis in water of a promising antituberculosis drug, 6-ethoxycarbonyl-5-methyl-7-(thien-2-yl)-4,7-dihydro[1,2,4]triazolo[1,5-a]pyrimidine, was developed. The amount of the solvent in the reaction mixture has a decisive effect on the yield and purity of the target product.
中文翻译:
三组分绿色合成 6-ethoxycarbonyl-5-methyl-7-(thien-2-yl)-4,7-dihydro[1,2,4]triazolo[1,5-a] 嘧啶,一种有前景的抗结核药物
一种新的简单、技术和环保的方法,用于在水中无催化剂合成有前景的抗结核药物 6-乙氧基羰基-5-甲基-7-(thien-2-yl)-4,7-dihydro[1, 2,4]三唑并[1,5-a]嘧啶被开发出来。反应混合物中溶剂的量对目标产物的产率和纯度具有决定性影响。
更新日期:2019-12-01
中文翻译:
三组分绿色合成 6-ethoxycarbonyl-5-methyl-7-(thien-2-yl)-4,7-dihydro[1,2,4]triazolo[1,5-a] 嘧啶,一种有前景的抗结核药物
一种新的简单、技术和环保的方法,用于在水中无催化剂合成有前景的抗结核药物 6-乙氧基羰基-5-甲基-7-(thien-2-yl)-4,7-dihydro[1, 2,4]三唑并[1,5-a]嘧啶被开发出来。反应混合物中溶剂的量对目标产物的产率和纯度具有决定性影响。